Collectors, Historians See Gold In Old Notebooks And Books

And Books Don't throw away that rough draft of your latest paper just yet, archivists advise. It may never have the multimillion-dollar value of Albert Einstein's draft chapter on special relativity (see story on page 3), but it may still be sought after by historians and collectors. Scientific memorabilia-including books, manuscripts, letters, instruments, and signatures-are actively collected. Einstein, who was a prolific letter writer, commands great attention and prices. So do Galileo, Kep

Written byBilly Goodman
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

And Books Don't throw away that rough draft of your latest paper just yet, archivists advise. It may never have the multimillion-dollar value of Albert Einstein's draft chapter on special relativity (see story on page 3), but it may still be sought after by historians and collectors.

Scientific memorabilia-including books, manuscripts, letters, instruments, and signatures-are actively collected. Einstein, who was a prolific letter writer, commands great attention and prices. So do Galileo, Kepler, Copernicus, Pasteur, Darwin, and Freud.

These and a few other scientists have achieved the household-name recognition required to send prices into the stratosphere. When Einstein's special relativity manuscript sold in 1987 for $1.2 million, it set a record for scientific manuscripts. Leonardo da Vinci's notebook set a record for any manuscript at auction when William H. Gates III, chairman of Redmond, Wash.-based Microsoft Corp., bought it in 1994 for $30.8 million. At these prices, it is "celebrities ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies